Literature DB >> 3961172

Cardiophrenic angle adenopathy: update of causes and significance.

P Vock, J Hodler.   

Abstract

Of 21 cases of cardiophrenic angle adenopathy (CAA) detected on computed tomography (CT) examination, 12 were due to malignant lymphomas, seven to carcinomas, and two to mesotheliomas. Of the nine lesions that were not malignant lymphomas, four were of supradiaphragmatic and five of infradiaphragmatic origin. On average, CAA was detected 4.6 years after the primary neoplasm was diagnosed. Only 29% of the patients were alive 14 months after CAA was detected on CT scans. Radiography was inferior to CT in the detection of CAA, with only 35% of radiography results clearly positive. Malignant lymphoma is a major but not exclusive cause of CAA, and it must be differentiated from lymphatic seeding of supradiaphragmatic and infradiaphragmatic malignancies. Unilateral CAA may point to supradiaphragmatic neoplasms or, if right-sided, to ovarian carcinoma, and bilateral CAA may indicate another neoplasm of infradiaphragmatic origin.

Entities:  

Mesh:

Year:  1986        PMID: 3961172     DOI: 10.1148/radiology.159.2.3961172

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature.

Authors:  Mahmut Kebapci; Eser Vardareli; Baki Adapinar; Mustafa Acikalin
Journal:  Eur Radiol       Date:  2003-03-25       Impact factor: 5.315

2.  The association of paracardial adenopathy with hepatic metastasis found on CT arterial portography.

Authors:  R J Wechsler; L N Nazarian; C K Grady; E J Halpern
Journal:  Abdom Imaging       Date:  1995 May-Jun

3.  Extrapleural and cardiophrenic lymph nodes: prevalence, clinical significance and diagnostic value.

Authors:  Beatrice Feragalli; Cesare Mantini; Nicoletta Civitareale; Roberta Polverosi; Armando Tartaro; Antonio Raffaele Cotroneo
Journal:  Radiol Med       Date:  2013-11-19       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.